People with neuromotor disability (i.e. following an inborn or acquired spinal cord, cerebral or peripheral neurological lesion) are at risk of worsening their neuro-orthopaedic disorders during aging, including fracture risk. Nevertheless, at the present time, the natural evolution of their neuro-orthopedic disorders and the long-term functional impact of their medical and surgical treatments is unknown. The aim of this study is to describe neuro-orthopedic disorders during aging of patients with neuromotor disability, their functional repercussions, their comorbidities and the therapeutic strategies used.
This is an ambispective, monocentric, cohort study of subjects with neuromotor disability followed in a Physical Medicine and Rehabilitation Department. All consecutive eligible inpatient and outpatient subjects treated in the Neuro Orthopaedic Unit (UPOH) of the Physical Medicine and Rehabilitation Department of our university hospital will be included. Data will be collected from the patients' medical records, in particular data related to their clinical, radiological, biological and physiological examinations.
Study Type
OBSERVATIONAL
Enrollment
2,000
clinical examination, radiological, biological and physiological examinations.
Department of Physical Medicine and Rehabilitation, Raymond Poincaré Hospital, AP-HP
Garches, France
RECRUITINGEvolution of mobility during aging
Walking range
Time frame: Through study completion, an average of 1 year
Prevalence of falls and fractures
Number and description of falls and fractures
Time frame: Through study completion, an average of 1 year
Characteristics of infiltrative procedures and surgeries
Number and description of infiltrative procedures and surgeries
Time frame: Through study completion, an average of 1 year
Changes of devices (orthoses and prostheses) and technical aids used during aging
Number and description of devices (orthoses and prostheses) and technical aids
Time frame: Through study completion, an average of 1 year
Changes of physical activity, as well as barriers and facilitators to physical activity, during aging
Questionnaires assessing physical activity levels (ex: PASPID) and barriers and facilitators to physical activity (ex: BPAQ)
Time frame: Through study completion, an average of 1 year
Evolution of comorbidities during aging
Prevalence of comorbidities (e.g. obesity, diabetes, hypertension, sleep apnea, ...)
Time frame: Through study completion, an average of 1 year
Medication
Medication list
Time frame: Through study completion, an average of 1 year
Prevalence of pressure sores
Number and description of pressure sores
Time frame: Through study completion, an average of 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.